Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | EVP and Pres. Global Regions | August 03, 2023 | August 07, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date August 03, 2023 · Filed August 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 56,799 |
Reported balance
After 2023-08-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-08-03 · Grant · Acquired 4,251 · Balance 56,799 F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2: Includes 49 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 52,748 |
Reported balance
After 2023-08-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-08-03 · Tax withholding · Disposed 4,051 · Balance 52,748 F3: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-08-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-08-03 · Exercise / conversion · Disposed 4,251 · Balance 0 F4: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5: The performance share units vested on August 3, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents.
F2: Includes 49 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1.
F3: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023.
F4: Each performance share unit represented a contingent right to receive one share of Medtronic common stock.
F5: The performance share units vested on August 3, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2017 Filed Aug 2, 2017 14:53 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 36,521 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-17-024703 · form4.xml · derivative · entry 2 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,521 Underlying: Ordinary Shares · 36,521 shares Expires 2027-07-31 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 14:53 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-024703 · form4.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,426 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 12:40 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 330 | $84.29 | $27,815.70 |
DisclosureSEC source: 0001127602-17-024468 · form4.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,295 F1 · balance_after: This balance increased by 387 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,117 | $0.00 Strike: $55.32 | $0.00 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · derivative · entry 9 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,514 Underlying: Ordinary Shares · 11,117 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase 14,823 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 14,823 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,357 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · derivative · entry 8 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,951 Underlying: Ordinary Shares · 10,357 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 20,714 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 20,714 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,129 | $0.00 Strike: $38.81 | $0.00 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · derivative · entry 7 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 21,129 shares Expires 2022-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 21,129 New Medtronic ordinary shares for $38.81per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 21,129 Medtronic common stock shares for $38.81per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,154 | $0.00 Strike: $37.53 | $0.00 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · derivative · entry 6 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,154 shares Expires 2020-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 8,154 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 8,154 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 50,757 | $81.58 | $4,140,593.64 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · nonDerivative · entry 5 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,238 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.301 to $82.098, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · balance_after: This balance increased by 386 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 11,117 | $55.32 | $614,992.44 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · nonDerivative · entry 4 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 10,357 | $62.76 | $650,005.32 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · nonDerivative · entry 3 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 21,129 | $38.81 | $820,016.49 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · nonDerivative · entry 2 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 18:07 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 8,154 | $37.53 | $306,019.62 |
DisclosureSEC source: 0001127602-17-012558 · form4.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.